. 1976 Oct;22(4):171-5.

In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination

P Anklesaria et al. J Postgrad Med. 1976 Oct.

. 1976 Oct;22(4):171-5.

No abstract available

Similar articles

In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim-nitrofuratoin combination.
Patil P, Sharma V, Joshi BN. Patil P, et al. J Postgrad Med. 1979 Jul;25(3):162-5. J Postgrad Med. 1979. PMID: 119047 No abstract available.
[Comparison of the antibacterial activity of sulfonamide-nitrofurantoin combinations of varying composition].
Roser H. Roser H. Arzneimittelforschung. 1973 Aug;23(8):1111-3. Arzneimittelforschung. 1973. PMID: 4588099 German. No abstract available.
Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Karlowsky JA, et al. Clin Infect Dis. 2003 Jan 15;36(2):183-7. doi: 10.1086/345754. Epub 2003 Jan 3. Clin Infect Dis. 2003. PMID: 12522750
[In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
Lebek G, Wiedmer E. Lebek G, et al. Schweiz Med Wochenschr. 1971 Sep 25;101(38):1385-90. Schweiz Med Wochenschr. 1971. PMID: 4946735 German. No abstract available.
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J. Garau J. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202. doi: 10.1111/j.1469-0691.2007.01852.x. Clin Microbiol Infect. 2008. PMID: 18154548 Review.